UVA acquires Extend to broaden the potential for Gamma Knife Perfexion

Patients with overly large benign skull base tumors, lesions too close to critical anatomy and those with multiple brain metastases are among those who will benefit first from a new "frameless" device for use with Leksell Gamma Knife Perfexion systems. The Extend program will enable University of Virginia Health System (UVA) clinicians to non-invasively fix or immobilize the patient's head position over two to five radiosurgery sessions, making it more practical for these cases.

"Team members from both the neurosurgery and radiation oncology departments made the decision to acquire Extend," said Jason Sheehan, M.D., Ph.D., an associate professor in both departments at UVA and co-director of UVA's Gamma Knife Center. "We wanted to expand the versatility of the Perfexion system to allow multi-session radiosurgery. This will enable us to treat lesions immediately adjacent to critical structures, such as the optic apparatus, in addition to targets that are simply too large for single session radiosurgery. It also creates the potential to treat brain metastases, which in many cases might not require the precision provided by a very rigid frame."

"There's no question that Extend broadens the potential for Gamma Knife Perfexion," added James Larner, M.D., professor and chair, radiation oncology. "First, fractionating therapy under certain circumstances -- cases in which a small tumor abuts a critical structure, for example -- provides a greater anti-tumor effect for a given level of normal tissue toxicity. Second, Extend is a non-invasive fixation alternative for Gamma Knife."

UVA is among the first U.S. centers to acquire Extend.

The key components of Extend are patient-friendly fixation devices, such as a vacuum assisted bite block and head support with vacuum pillow. Accurate repeat fixation is ensured with a one-time use of a CT box to obtain precise stereotactic reference points, followed by repeat checks using reposition check instruments for each Gamma Knife session.

Elekta will deliver Extend to UVA in mid-December and Dr. Sheehan anticipates treating their first patients in January 2010.

UVA acquired Leksell Gamma Knife® in 1989. In 2007, it was the first U.S. medical center to install Leksell Gamma Knife Perfexion, the most advanced radiosurgery solution available. UVA has performed Gamma Knife surgery on about 7,000 patients.

SOURCE Elekta, Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Elekta. (2023, September 12). UVA acquires Extend to broaden the potential for Gamma Knife Perfexion. News-Medical. Retrieved on November 22, 2024 from https://www.news-medical.net/news/20091218/UVA-acquires-Extend-to-broaden-the-potential-for-Gamma-Knife-Perfexion.aspx.

  • MLA

    Elekta. "UVA acquires Extend to broaden the potential for Gamma Knife Perfexion". News-Medical. 22 November 2024. <https://www.news-medical.net/news/20091218/UVA-acquires-Extend-to-broaden-the-potential-for-Gamma-Knife-Perfexion.aspx>.

  • Chicago

    Elekta. "UVA acquires Extend to broaden the potential for Gamma Knife Perfexion". News-Medical. https://www.news-medical.net/news/20091218/UVA-acquires-Extend-to-broaden-the-potential-for-Gamma-Knife-Perfexion.aspx. (accessed November 22, 2024).

  • Harvard

    Elekta. 2023. UVA acquires Extend to broaden the potential for Gamma Knife Perfexion. News-Medical, viewed 22 November 2024, https://www.news-medical.net/news/20091218/UVA-acquires-Extend-to-broaden-the-potential-for-Gamma-Knife-Perfexion.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New PULSAR radiation-therapy strategy achieves better tumor control